Progress Technologies Group Inc (339A)

Tokyo

Currency in JPY

909.00

+5.00(+0.55%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

903.00

920.00

52 wk Range

843.00

1,594.00

Progress Technologies (339A) Income Statement & Profits

Assess the Progress Technologies income statement (earnings report) to see how the company performs across operating and non-operating activities, including revenue, expenses and net income. Review 339A diluted EPS and profitability over the last four annual or quarterly periods.

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Period Ending:

2023

28/02

2024

29/02

2025

28/02

2026

28/02

Total Revenues

4,780

5,116

5,649

6,314

Total Revenues Growth

+7.03%

+10.42%

+11.77%

Cost Of Revenues

2,672

2,890

3,056

3,421

Gross Profit

2,108

2,226

2,593

2,893

Gross Profit Growth

+5.6%

+16.49%

+11.57%

Gross Profit Margin %

44.1%

43.51%

45.9%

45.82%

Other Operating Expenses, Total

917

1,075

1,177

1,108

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

-	+17.23%	+9.49%	-5.86%
-	-	-	-
919	1,074	1,174	1,315
-2	1	3	-207

Operating Income

1,191

1,151

1,416

1,785

Operating Income Growth

-3.36%

+23.02%

+26.06%

EBIT Margin %

24.92%

22.5%

25.07%

28.27%

Net Interest Expenses

-119

-154

-55

-61

Net Interest Expenses Growth

-29.41%

+64.29%

-10.91%

Interest Expense, Total

-120

-155

-56

-68

Interest And Investment Income

Other Non Operating Expenses, Total

-1

-6

EBT, Excl. Unusual Items

1,071

996

1,355

1,718

Gain (Loss) On Sale Of Assets

Other Unusual Items, Total

-500

EBT, Incl. Unusual Items

1,071

996

855

1,718

EBT, Incl. Unusual Items Growth

-7%

-14.16%

+100.94%

EBT, Incl. Unusual Items Margin

22.41%

19.47%

15.14%

27.21%

Income Tax Expense

341

300

271

537

Net Income to Company

730

696

584

1,181

Minority Interest

Net Income

730

696

584

1,181

Net Income Growth

-4.66%

-16.09%

+102.23%

Net Income Margin %

15.27%

13.6%

10.34%

18.7%

Preferred Dividend and Other Adjustments

Net Income to Common Excl. Extra Items

730

696

584

1,181

Basic EPS - Continuing Operations

103.22

98.41

82.58

152.92

Basic EPS - Continuing Operations Growth

-4.66%

-16.09%

+85.18%

Diluted EPS - Continuing Operations

103.22

98.41

82.58

148.36

Diluted EPS - Continuing Operations Growth

-4.66%

-16.09%

+79.66%

Basic Weighted Average Shares Outstanding

7.07

7.72

Diluted Weighted Average Shares Outstanding

7.07

7.97

Dividend Per Share

Dividend Per Share Growth

EBITDA

1,570

1,992

EBITDA Growth

+26.88%

EBITDA Margin %

27.79%

31.55%

EBIT

1,191

1,151

1,416

1,785

* In Millions of JPY (except for per share items)

FAQ

What was the quarter-over-quarter change in EBITDA for Progress Technologies?

339A's EBITDA changed by -31.42% compared to the last quarter.

How did Progress Technologies’s revenue change compared to the previous quarter?

Revenue changed by -7.59% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Progress Technologies?

In the latest quarter, Progress Technologies's gross profit changed by -17.38%.

FTSE 100

10,658.13

-39.44

-0.37%

DAX

25,423.47

-17.34

-0.07%

Euro Stoxx 50

6,238.10

-22.28

-0.36%

S&P 500

7,582.30

-37.66

-0.49%

Nikkei 225

63,484.10

-8.89

-0.01%

Dow Jones

52,058.82

-362.38

-0.69%

FTSE 100 Futures

10,753.50

-15.5

-0.14%

Market Movers

Name	Last	Chg. %	Vol.
Lloyds Banking	108.89	-0.42%	560.00M
BP	580.30	+1.59%	90.73M
NatWest Group	689.20	+0.94%	72.04M
HSBC	1,503.80	-2.15%	26.06M
AstraZeneca	12,116.0	-0.31%	3.03M
Barclays	470.30	-1.71%	74.04M
Rolls-Royce Holdings	1,420.20	-0.25%	16.50M

Name	Last	Chg. %	Vol.
Rapid Nutrition	2.7600	+100,000.00%	164.00
Telecom Italia	7.603	+868.53%	811.41K
Nobia AB	13.99	+672.93%	6.59K
Energous Co	10.77	+548.80%	132.00
Trane Technologies	419.48	+375.76%	540.00
Marathon Petroleum	406.9300	+271.49%	3.88K
Scandi Standard publ AB	147.40	+175.51%	1.19K

Name	Last	Chg. %	Vol.
Booking	170.6	-96.52%	8.06K
Next Biometrics	0.27	-93.76%	4.79K
Kala Pharma	0.53	-92.30%	796.00
iQIYI	1.02	-91.97%	5.08K
Kinnevik AB	69.70	-84.16%	333.00
KLA Corp	167.67	-78.75%	17.90K
Inovio	1.16	-77.90%	10.88K

Trending Stocks

Name	Last	Chg. %	Vol.
Barclays	470.30	-1.71%	74.04M
GCM Resources	16.25	-13.33%	14.22M
Avacta Group	80.00	+5.96%	4.50M
Rolls-Royce Holdings	1,420.20	-0.25%	16.50M
Orosur	16.60	+28.09%	18.44M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aaa	293.50	+42.34%	417.77
Aa A Aaaaaa	276.40	+37.73%	380.69
A Aaa Aaaaa Aaa A	2,516.00	+31.30%	3,303.51
Aa Aaa Aaaaaaaaa	712.00	+27.05%	904.60
Aaaaaaaaaaaaaaaa	580.30	+26.60%	734.66
Aaaaaaaaaaaaa Aaaaa	1,609.0	+26.23%	2,031.0
A Aaaaa Aaaaaaa	1,854.00	+24.57%	2,309.53

Name	Last	Upside	Fair Value
Aaaa Aaa	293.50	+42.34%	417.77
Aa A Aaaaaa	276.40	+37.73%	380.69
A Aaa Aaaaa Aaa A	2,516.00	+31.30%	3,303.51
Aa Aaa Aaaaaaaaa	712.00	+27.05%	904.60
Aaaaaaaaaaaaaaaa	580.30	+26.60%	734.66
Aaaaaaaaaaaaa Aaaaa	1,609.0	+26.23%	2,031.0
A Aaaaa Aaaaaaa	1,854.00	+24.57%	2,309.53

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Progress Technologies Group Inc (339A)

Progress Technologies (339A) Income Statement & Profits

FAQ

What was the quarter-over-quarter change in EBITDA for Progress Technologies?

How did Progress Technologies’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Progress Technologies?

Trending Stocks